Tempus AI, Inc. (TEM) Stock
Tempus AI stock price chart
TEM stock quote & key statistics
Tempus AI annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $1.27B | -$245.0M | -$0.61 |
| FY2024 | $693.4M | -$705.8M | -$2.04 |
| FY2023 | $531.8M | -$214.1M | — |
| FY2022 | $320.7M | -$289.8M | — |
| FY2021 | $257.9M | -$259.2M | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About Tempus AI, Inc.
Tempus AI, Inc. Class A is dedicated to revolutionizing precision medicine through the practical application of artificial intelligence in healthcare. At the core of our mission is the development of Intelligent Diagnostics, leveraging AI technologies, including generative AI, to enhance the accuracy, customization, and personalization of laboratory tests.
Central to our approach is the Tempus Platform, a comprehensive technology and operating system designed to liberate healthcare data from silos and transform it into actionable insights. This platform has enabled us to compile one of the largest repositories of clinical and molecular oncology data globally, empowering groundbreaking research and clinical decision-making.
Since our inception, we have successfully launched a diverse portfolio of products derived from the Tempus Platform, garnering significant adoption across the healthcare industry. Our solutions have been embraced by approximately 95% of the largest public pharmaceutical companies, underscoring our leadership in advancing the field of precision medicine through innovative AI-driven diagnostics and therapeutic insights.
Tempus AI stock FAQ
What is the Tempus AI stock ticker symbol?
Tempus AI, Inc. trades on the NASDAQ under the ticker symbol TEM.
What sector and industry is Tempus AI in?
Tempus AI, Inc. is classified in the Healthcare sector, Health Information Services industry.
How many employees does Tempus AI have?
Tempus AI, Inc. has about 3,800 full-time employees.
What were Tempus AI's revenue and earnings last fiscal year?
Tempus AI reported revenue of $1.27B and net income of -$245.0M in fiscal 2025, with earnings per share of -$0.61. Revenue grew 83.4% from the prior year.
Is Tempus AI in the Russell 1000?
Yes. Tempus AI, Inc. (TEM) is a component of the Russell 1000, which tracks roughly the 1,000 largest U.S. companies.
When did Tempus AI go public?
Tempus AI stock began trading on June 14, 2024.
Russell 1000 Healthcare stocks
All Russell 1000 →- ABBVAbbVie
- ABTAbbott
- AMGNAmgen
- BMYBristol Myers Squibb
- CICigna
- CVSCVS Health
- DHRDanaher
- DOCSDoximity
- ELVElevance Health
- GILDGilead
- ISRGIntuitive Surgical
- JNJJohnson & Johnson
- LLYEli Lilly
- MCKMcKesson
- MDTMedtronic
- MRKMerck
- MRNAModerna
- PFEPfizer
- REGNRegeneron
- SYKStryker
- TMOThermo Fisher
- UNHUnitedHealth
- VEEVVeeva
- VRTXVertex